Chemoinformaics analysis of 2,4-bis (1,1-dimethylethyl)
| Molecular Weight | 368.666 | nRot | 5 |
| Heavy Atom Molecular Weight | 332.378 | nRig | 6 |
| Exact Molecular Weight | 368.22 | nRing | 1 |
| Solubility: LogS | -6.934 | nHRing | 0 |
| Solubility: LogP | 5.955 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 60 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 1 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 36 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 69.2005 |
| nHD | 1 | BPOL | 70.4675 |
| QED | 0.653 |
| Synth | 2.655 |
| Natural Product Likeliness | 0.105 |
| NR-PPAR-gamma | 0.013 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.033 |
| Pgp-sub | 0.005 |
| HIA | 0.921 |
| CACO-2 | -4.988 |
| MDCK | 0.0000104 |
| BBB | 0.011 |
| PPB | 1.03149 |
| VDSS | 5.669 |
| FU | 0.00620871 |
| CYP1A2-inh | 0.69 |
| CYP1A2-sub | 0.961 |
| CYP2c19-inh | 0.833 |
| CYP2c19-sub | 0.924 |
| CYP2c9-inh | 0.696 |
| CYP2c9-sub | 0.918 |
| CYP2d6-inh | 0.356 |
| CYP2d6-sub | 0.922 |
| CYP3a4-inh | 0.706 |
| CYP3a4-sub | 0.558 |
| CL | 3.804 |
| T12 | 0.768 |
| hERG | 0.014 |
| Ames | 0.023 |
| ROA | 0.042 |
| SkinSen | 0.04 |
| Carcinogencity | 0.021 |
| EI | 0.987 |
| Respiratory | 0.461 |
| NR-Aromatase | 0.374 |
| Antiviral | Yes |
| Prediction | 0.651605 |